LONDON (Alliance News) - Ilika PLC on Wednesday said it has developed new processing methods to enable rapid customisation of its Stereax battery technology to match customers' requirements for form, fit and function.
Ilika shares were trading 13% higher at 33.95 pence each.
The company explained it replaced the use of contact masks in the development of its Stereax products with a photolithographic method.
"The replacement of contact masks with a photolithographic method is an important step in being able to offer customised solutions to high value proprietary applications for Stereax products," Chief Executive Officer Graeme Purdy said.
Photolithography is a microfabrication method in the semiconductor industry, Ilika explained. It has the advantage over contact masks of being able to create smaller feature sizes.
Additionally, the time of the process is reduced by up to 85%, making it possible to respond to customers' requirements in "an accelerated manner".
Also, the operating costs of using a photolithographic process are significantly less, Ilika added.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:


UK shareholder meetings calendar - next 7 days


TRADING UPDATES: Argo gets GBP18 million loan; Genedrive fundraises


EXECUTIVE CHANGES: British Honey on hunt for new chair


TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress


(Sharecast News) - Solid-state battery technology company Ilika updated the market on progress in implementing its 'Stereax' manufacturing plans on Tu...


TRADING UPDATES: President seeks hydrogen; Telit faces more dissent


Ilika to raise GBP25 million to accelerate Goliath programme


AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle